Clade Therapeutics, Inc.
Pharmaceutical company · Cambridge, Massachusetts, United States
Clade Therapeutics, Inc. is a pharmaceutical company headquartered in Cambridge, Massachusetts, United States. Its earliest recorded incorporation is in 2020. It has reported private securities offerings to the US SEC, most recently $42,000 sold in a notice filed in 2022.
Clade Therapeutics at a glance
What does Clade Therapeutics do?
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $42,000 sold (2022).
Frequently asked questions about Clade Therapeutics
Where is Clade Therapeutics headquartered?
Clade Therapeutics, Inc. is headquartered in Cambridge, Massachusetts, United States.
What does Clade Therapeutics do?
Clade Therapeutics, Inc. is a pharmaceutical company.
When was Clade Therapeutics founded?
The earliest incorporation on record for Clade Therapeutics, Inc. is in 2020, according to public company registers.
Similar companies
- Spero Therapeutics, Inc.Cambridge, Massachusetts, United States
- Sarepta Therapeutics, Inc.Cambridge, Massachusetts, United States
- Alnylam Pharmaceuticals, Inc.Cambridge, Massachusetts, United States
- Visterra, Inc.Cambridge, Massachusetts, United States
- Seres Therapeutics, Inc.Cambridge, Massachusetts, United States
- Merrimack Pharmaceuticals IncCambridge, Massachusetts, United States
- QurAlis CorpCambridge, Massachusetts, United States
- Apnimed, Inc.Cambridge, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences